These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5749977)

  • 1. [Psychiatric and neurological symptoms caused by cycloserine poisoning].
    Nakamura K
    Seishin Shinkeigaku Zasshi; 1968 Jun; 70(6):503-21. PubMed ID: 5749977
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P; Turell Gumá J
    Rev Clin Esp; 1968 Apr; 109(2):117-26. PubMed ID: 4904020
    [No Abstract]   [Full Text] [Related]  

  • 6. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
    Horsfall PA
    Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine].
    Schumann C
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):295-302. PubMed ID: 5756628
    [No Abstract]   [Full Text] [Related]  

  • 10. Retreatment of drug resistant tuberculosis at Battey State Hospital.
    Corpe RF; Blalock FA
    Dis Chest; 1965 Sep; 48(3):305-10. PubMed ID: 5830645
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
    Utkin VV
    Probl Tuberk; 1973; 51(1):12-6. PubMed ID: 4727151
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults.
    Bucco T; Meligrana G; De Luca V
    Scand J Respir Dis Suppl; 1970; 71():259-65. PubMed ID: 5271998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 17. Personal experience with cycloserine in 206 patients with pulmonary tuberculosis.
    Villar TG
    Scand J Respir Dis Suppl; 1970; 71():196-200. PubMed ID: 5271986
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 19. On the treatment of primary tuberculosis in tender age (0-5 years) with resistomycin, cycloserine, and ethionamid.
    Dobrev P; Slaveykova A; Lankova D
    Nauchni Tr Vissh Med Inst Sofiia; 1966; 45(5):37-42. PubMed ID: 4228990
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to cycloserine.
    Riska N
    Scand J Respir Dis Suppl; 1970; 71():209-16. PubMed ID: 5271988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.